VEGF Antikörper (AA 27-233)
(2 Referenzen)Kurzübersicht für VEGF Antikörper (AA 27-233) (ABIN2735205)
Target
Alle VEGF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 27-233
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli.
-
Isotyp
- IgG2b
-
-
anti-Vascular Endothelial Growth Factor (VEGF) (AA 27-120) antibody
VEGF Reaktivität: Human, Maus, Ratte, Schwein, Ziege WB, ELISA, IHC (p), IHC (fro), IF (p), FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte, Hund, Schwein, Rind (Kuh), Huhn WB, IHC (p), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) (C-Term) antibodyVEGF Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB11705 unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Ratte WB, ELISA, IHC, IP, FACS, BR Wirt: Maus Monoclonal A-4-6-1 unconjugated Recombinant Antibody
anti-Vascular Endothelial Growth Factor (VEGF) (AA 27-233) antibodyVEGF Reaktivität: Human WB, IHC, IF Wirt: Maus Monoclonal 4E3 unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) (full length) antibodyVEGF Reaktivität: Human, Maus, Schwein WB, IF Wirt: Huhn Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Ratte IF Wirt: Kaninchen Polyclonal unconjugated
anti-Vascular Endothelial Growth Factor (VEGF) antibodyVEGF Reaktivität: Human, Maus, Primate WB, ELISA, IHC Wirt: Maus Monoclonal VG76e unconjugated Recombinant Antibody
anti-Vascular Endothelial Growth Factor (VEGF) (N-Term) antibodyVEGF Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- WB 1:2500~5000, IHC: 1:50-1:150,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
: "The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer." in: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1257-1271, (2018) (PubMed).
-
: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
-
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
Andere Bezeichnung
- VEGF
-
Molekulargewicht
- 23.8 kDa
-
Gen-ID
- 7422
-
NCBI Accession
- NM_001025366
-
HGNC
- 7422
Target
-
